H.C. Wainwright adjusted its outlook on Cullinan Oncology Inc. (NASDAQ:CGEM), raising the price target to $33.00 from the previous $28.00 while maintaining a Buy rating on the company's shares.
Currently at 61%, the Philippines remains short of its target of completely immunizing 95% of children against ...